Your Messages Inbox
Your Article Summary
See Latest ArticlesProduct Provides Significant New Option for Certain Cancer Patients Requiring a Stem Cell Transplant
Genzyme, 08/06/09
Genzyme Corporation announced that the European Commission has granted marketing authorization for Mozobil (plerixafor injection), providing a significant new option for patients with the blood cancers lymphoma and multiple myeloma who require an autologous stem cell transplant.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor